Remark Holdings Enters into Debt Exchange Agreement with Mudrick Capital Management, L.P., Resolving All Previous Default Issues

Stock Information for NeuroSense Therapeutics Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About NeuroSense Therapeutics Ltd.

Remark Holdings Collaborates with Google Public Sector to Accelerate Computer Vision AI Innovation in New York State
Remark AI Announces Real-Time Drone Video Analytics Platform
Remark Holdings Uses Regulation A to Offer $75 Million of Cumulative Redeemable Perpetual Preferred Stock Paying 15% Dividend
Remark AI Successfully Optimized on Intel Architecture
Remark Holdings to present at Oracle Cloud World 2024 as part of the Data and AI Pavilion accelerated by NVIDIA
Remark Holdings Announces Second Quarter 2024 Financial Results
Remark Holdings Sets Second Quarter 2024 Financial Results Call for August 19, 2024, at 4:30 p.m. ET
/C O R R E C T I O N -- Remark Holdings, Inc./

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.